Episode 1606 • • 15:29 - 20:46
1606: Food Noise
Eli Lilly Zepbound, Obesity Opportunity and Pharma Marketing
The FDA approved Eli Lilly’s drug Zepbound for chronic weight management, which is a rebranded version of the diabetes drug Mounjaro. Financial analysts describe the "obesity opportunity" as potentially the largest pharmaceutical market in history, with marketing budgets expected to reach record highs.